In vivo evaluation of single dose tetanus toxoid vaccine formulation with chitosan microspheres

Indian Journal of Pharmaceutical Sciences

Volumn 70, Issue 1, 2008, Pages 11-15

  Manivannan, R ^b   Dhanaraj, S ^a   Rao, Y ^c   Balasubramaniam, A ^b   Gowrishankar, N ^b   Jawahar, N ^b   Jubie, S ^b  

^a JSS COLLEGE OF PHARMACY   (India)

^b SWAMY VIVEKANANDHA COLLEGE OF PHARMACY   (India)

^c Pasteur Institute of India   (India)

Author keywords

Chitosan; Microspheres; Tetanus antitoxin; Tetanus toxin; Tetanus toxoid

Indexed keywords

ANTITOXIN; CHITOSAN; MICROSPHERE; TETANUS TOXOID;

AGITATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ADSORPTION; DRUG FORMULATION; DRUG RELEASE; FLOCCULATION; GUINEA PIG; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; METHODOLOGY; MOUSE STRAIN; NONHUMAN; SERUM; SINGLE DRUG DOSE; TITRIMETRY;

EID: 43449090400     PISSN: 0250474X     EISSN: 19983743     Source Type: Journal    
DOI: 10.4103/0250-474X.40325     Document Type: Article

References (11)

1. Alonso MJ, Gupta RK, Caroline Min, Siber GR, Langer R. Biodegradable microspheres as controlled release tetanus toxoid delivery systems. Vaccine 1994;12:299.
2. Diwan M, Misra A, Khar RK, Talwar, GP. Long-term high immune response to diphtheria toxoid in rodents with diphtheria toxoid conjucated to dextran as a single contact point delivery system. Vaccine 1997;15:1867.
3. Christensen PE. Third Inter Conf Tetanus, Sao Paulo; Brazil: 17-22, 1970;PAHO/WHO Scientific publication, No.253, 1972. p. 36.
4. Illum L. Chitosan and its use as a pharmaceutical excipient. Pharm Res 1978;15:1326.
5. Felt O, Buri P Gurny R. Chitosan: A unique polysaccharide for drug delivery. Drug Develop Ind Pharm 1998;24:979.
6. st century; A review. STP Pharma Sci 2000;10:5.
7. Yuichi O, Shiratani M, Kobayashi H, Ouchi T. Release behavior of 5-flurouracil from chitosan-gel microspheres immobilizing 5-flurouracil coated with polysaccharides and their cell specific cytotoxicity. Pure Appl Chem 1994;31:629.
8. Jayakrishnan A, Jameelaa SR, Misra A. Cross-linked chitosan microspheres for prolonged delivery of macromolecular drugs. J Biomater Sci Polymer Edn 1994;6:621.
9. Indian Pharmacopoeia Vol II, Delhi: Controller of Publications; 1996. p. A-33.
10. Calcagno ML, Manghi MA. A possible explanation for the discrepancy between ELISA and neutralising antibodies to tetanus toxin. Vaccine 2000;18:2698.
11. Gupta RK, Alroy J, Alonso MJ, Langer R, Siber GR. Chronic local tissue reactons, long term immunogenicity and immunologic priming of mice and guineapigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of polylactide-co-glycolide polymers. Vaccine 1997;153:1716.